Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Nikolaos I. Kanellakis, Kevin Lamote. Management of incidental nodules in lung cancer screening: ready for prime-time?. Breathe, 15 (4) 346; 10.1183/20734735.0247-2019

Member's Comments

No comment yet.

Related content which might interest you: Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Active TB in cancer patients: A missed screening opportunity? Source: International Congress 2015 – Screening strategies in TB Year: 2015 Rapid access lung cancer clinics: do you have one? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Profile and nodule characteristics of patients with incidental solid pulmonary nodules Source: International Congress 2016 – A view into a chest and pleural pathology Year: 2016 Shall we disclose the diagnosis of lung cancer to the patient? Source: Eur Respir J 2006; 28: Suppl. 50, 40s Year: 2006 Profile and nodule characteristics of patients with incidental subsolid pulmonary nodules (SSN) Source: International Congress 2016 – A view into a chest and pleural pathology Year: 2016 Benign or malignant ? - a tricky solitary pulmonary nodule in a patient at high risk for lung cancer Source: International Congress 2017 – GR2 Lung Cancer Grand Round Year: 2017 Breath biomarkers for lung cancer detection: ready for use by the pulmonologist? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 ERS School Course Early-stage lung cancer - What's new in the epidemiology of lung cancer: the female aspect Source: ISSN=ISSN 1810-6838, ISBN=, page=339 Year: 2006 Diffuse parenchymal lung disease: a practical overview Is a lung biopsy necessary for management? Source: Breathe 2008; 4: 233-239 Year: 2008 Lung cancer assessment clinics: the fast track to bad news? Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Diagnosing lung cancer: is the 28 day rule appropriate? Source: Eur Respir J 2004; 24: Suppl. 48, 298s Year: 2004 Lung cancer screening - what does it mean for our practice? Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020 Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 The outcome of lymph nodes previously sampled with EBUS-TBNA and deemed "inadequate" - what lessons can be learnt? Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond Year: 2013 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Repeat diagnostic thoracocentesis in lung cancer staging – fiddling whilst Rome burns? Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007